A piece of good news for travellers as the Australian government has decided to approve India-made Covaxin for travel purposes. On Monday, the government recognised the Bharath Biotech Covaxin vaccine adding this as an approved vaccine for travellers’ vaccination status.
Speaking about this news, Australia High Commissioner to India Barry O’Farrell announced on Twitter, “Today, the Therapeutic Goods Administration determined that Covaxin (manufactured by Bharat Biotech) vaccine would be ‘recognised’ for the purpose of establishing a traveller’s vaccination status.”
He further wrote, “Importantly, recognition of Covaxin, along with the previously announced recognition of Covishield (manufactured by AstraZeneca India), means many citizens, as well as other countries, will now be considered fully vaccinated on entry to Australia.”
A statement released by Australia’s Department of Health informed that Therapeutic Goods Administration (TGA) has the information demonstrating that these vaccines can provide protection and also reduce the risk that an incoming traveller can transmit covid.
This move helps various Indian’s who have been administered covaxin can travel to Australia and because World Health Organization (WHO) has still not approved Covaxin as an approved vaccine, this is a huge move.
WHO had previously said, “decided that additional clarifications from the manufacturer (Bharat Biotech) are needed to conduct a final EUL risk-benefit assessment for global use of the Covaxin vaccine”.